News > India approves Covaxin, Covishield for emergency use

India approves Covaxin, Covishield for emergency use

Rediff.com | 03/01/2021 01:54 PM | Click to read full article

India's drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.

The Serum Institute of India, the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.

-